38. Allergie-Kolloquium - „Update Allergologie“
Datum:
08.+09.06.2026
Veranstaltungsort:
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisnau, Moldova
Antimicrobial resistance (AMR) is one of the most pressing global health challenges of the 21st century. Tuberculosis (TB) is a major contributor to this burden, with an estimated 390,000 people developing multidrug- or rifampicin-resistant TB (MDR/RR-TB) in 2024. Reflecting its global importance, the World Health Organization (WHO) has identified rifampicin-resistant Mycobacterium tuberculosis as a priority pathogen requiring urgent action.
While antimicrobial stewardship (AMS) is central to addressing AMR, TB-specific AMS approaches remain poorly defined. To address this gap, an international Delphi panel recently developed consensus-based clinical standards for AMS in TB (DOI: 10.5588/ijtldopen.25.0522). In a next step we are surveying the implementation of the standards in countries of this Region.
At this conference, organized by TBnet in collaboration with WHO Europe, results from the survey on the status of implementation of AMS standards in TB in region will be presented and we will discuss how to move AMS standards in TB into practice where they are missing. This conference brings together experts from across the wide WHO European Region in order to find practical strategies to strengthen AMS in TB.
Registrierung:
https://us06web.zoom.us/meeting/register/hrVrZe7KRcujo4q6OgiiOg
Das Programm können Sie hier herunterladen!
Kontakt:
Anne Oleischeick Forschungszentrum Borstel, Leibniz Lungenzentrum
Parkallee 35, D-23845 Borstel